Brief: BB Biotech Q3 Net Loss At CHF 382 Mln
Oct 18 (Reuters) - BB BIOTECH AG BION.S :
* NET PROFIT FOR PERIOD ENDED SEPTEMBER 30, 2019 AMOUNTED TO
CHF
172 MN (PROFIT OF CHF 172 MN IN SAME PERIOD 2018)
* IN Q3 A LOSS OF CHF 382 MN (PROFIT OF CHF 242 MN IN
CORRESPONDING PERIOD OF PREVIOUS YEAR)
Source text for Eikon: ID:nEQ6Bdsfsa
Further company coverage: BION.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Bb Biotech AG
See all newsBrief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
Brief: BB BIOTECH Q1 Net Income CHF -21 Million
Brief: BB Biotech Says All Proposals Of Board Of Directors Approved At AGM